Yucheng Technologies Ltd. reports that for a second year the company has ranked in the FinTech 100. The rankings are made on selection criteria which include key applications in the banking sector including: core processing, branch, tellers, loan management, credit card, mortgage origination, CRM, online banking and cash management, along with many other services.
Yucheng is a turnkey solutions provider with products that serve banking needs from front office solutions, such as e-banking, to back office and risk management. Yucheng currently has the widest portfolio of IT solutions targeted to banks in China.
Mr. Weidong Hong, CEO of Yucheng Technologies, commented, “Yucheng’s exclusive focus on the banking sector in China makes it uniquely able to provide customized solutions that meet banks’ rapidly developing requirements,” “This win acknowledges the importance of the Chinese banking market and Yucheng’s contribution to developing superior solutions for banks.”
The FinTech 100 survey has been tracking industry leaders for the last six years. It is an annual listing of top technology companies chosen by American Banker, Bank Technology News (BTN) and IDC Financial Insights.
Yucheng Technologies Limited is a leading IT service provider to the Chinese banking industry. Headquartered in Beijing, China, Yucheng has approximately 2,200 employees and an extensive network for serving banking clients nationwide in 23 cities.
About QualityStocks:
QualityStocks’ Small Cap Stock Newsletter is a free service that collects data from hundreds of Small-Cap online Investment Newsletters into one free Daily Newsletter Report.
Sign up for “The QualityStocks Daily Newsletter” please visit www.QualityStocks.net
The Quality Stocks Daily Stock Report http://video.qualitystocks.net
The Quality Stocks Daily Blog http://blog.qualitystocks.net
The Quality Stocks “Ones to Watch” http://Gotstocks.QualityStocks.net
Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment